Last Posted: Sep 03, 2020
- Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450
V Hlavac et al, J Per Med, August 2020 - CYP2D6 Expression in Veterans Experiencing Opioid Overdose: A Postmortem Review.
Boyle Julia et al. Pharmacogenomics and personalized medicine 2020 13289-293 - Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine Consortium.
Gregornik David et al. The pharmacogenomics journal 2020 Aug - Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
Roosan Don et al. The pharmacogenomics journal 2020 Aug - Pharmacogenomics of COVID-19 therapies.
Takahashi Takuto et al. NPJ genomic medicine 2020 535 - CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions: One Size Rarely Fits All.
Moliterno David J et al. JAMA 2020 08 (8) 747-749 - Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children’s Genomic Medicine Consortium
D Gregornik et al, Pharmacogenetics Journal, August 26, 2020 - Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists.
Edris Ahmed et al. The pharmacogenomics journal 2020 Aug - Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence.
Gower Megan N et al. Pharmacogenomics and personalized medicine 2020 13239-252 - Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
Fan Mikayla et al. Pharmacogenetics and genomics 2020 Aug
.png)
No hay comentarios:
Publicar un comentario